Intestinal Drug Absorption After Subarachnoid Hemorrhage and Elective Neurosurgery: Insights From Esomeprazole Pharmacokinetics
Open Access
- 20 November 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 53 (1) , e140-e150
Abstract
OBJECTIVES: Subarachnoid hemorrhage (SAH) may critically impair cardiovascular, metabolic, and gastrointestinal function. Previous research has demonstrated compromised drug absorption in this group of patients. This study aimed to examine the impact of SAH on gastrointestinal function and its subsequent effect on the absorption of enterally administered drugs, using esomeprazole as a probe drug. DESIGN: Prospective observational cohort study. SETTING: Academic hospital in Germany. PATIENTS: We included 17 patients with high-grade SAH and 17 controls, comparable in age, sex, body weight, and renal function, who underwent elective cranial surgery. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Both groups received esomeprazole per standard protocol to prevent acid-associated mucosal damage, either orally or through a nasogastric tube. On day 4, esomeprazole was administered IV to estimate oral bioavailability. Esomeprazole serum concentrations were measured on days 1, 3, and 4 in both groups and on day 7 in the SAH group. Patients with high-grade SAH exhibited severely impaired drug absorption. Most patients showed no improvement in intestinal drug absorption even a week after hemorrhage. CONCLUSIONS: Following SAH, significantly reduced drug absorption may be attributed to decreased intestinal motility and compromised intestinal mucosal function. Clinicians should anticipate the reduced effectiveness of enterally administered medications for at least seven days after high-grade SAH.Keywords
This publication has 37 references indexed in Scilit:
- Current practice of stress ulcer prophylaxis in a surgical patient cohort in a German university hospitalLangenbeck's Archives of Surgery, 2021
- Stress-Related Gastrointestinal Bleeding in Patients with Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Observational StudyNeurocritical Care, 2020
- Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid HemorrhageNeurocritical Care, 2017
- Impact of early nutrition and feeding route on outcomes of mechanically ventilated patients with shock: a post hoc marginal structural model studyIntensive Care Medicine, 2015
- Augmented Renal Clearance in Patients with Subarachnoid HemorrhageNeurocritical Care, 2015
- Serum levels of nimodipine in enteral and parenteral administration in patients with aneurysmal subarachnoid hemorrhageActa Neurochirurgica, 2015
- Plasma citrulline kinetics and prognostic value in critically ill patientsIntensive Care Medicine, 2010
- Early-phase pharmacokinetics of enteral and parenteral nimodipine in patients with acute subarachnoid haemorrhage – a pilot studyEuropean Journal of Clinical Pharmacology, 2007
- Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management?Intensive Care Medicine, 2002
- Gastric tonometry after subarachnoid hemorrhageIntensive Care Medicine, 2001